Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Jukema

Showing results (121-130 of 202) with videos related to

Pageof 21
Sort By:
Journal of the American College of Cardiology|June 17, 1998
B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)E de Groot, J W Jukema, A D Montauban van Swijndregt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient miceR de Nooijer, J H von der Thüsen, C J N Verkleij, et al.
Circulation|May 15, 1995
Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)J W Jukema, A V Bruschke, A J van Boven, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
International Journal of Cardiology|April 7, 2018
The role of CD27-CD70-mediated T cell co-stimulation in vasculogenesis, arteriogenesis and angiogenesisK H Simons, Z Aref, H A B Peters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2005
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesisR de Nooijer, C J N Verkleij, J H von der Thüsen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2017
Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general populationI A Dekkers, R de Mutsert, A P J de Vries, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 8, 2019
Indications for an early invasive strategy in NSTE-ACS patientsB Zwart, J M Ten Berg, A W van 't Hof, et al.
Clinical Genetics|April 10, 2002
ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levelsK Y Zwarts, S M Clee, A H Zwinderman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 9, 2017
Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX scoreJ M Montero-Cabezas, I Karalis, R Wolterbeek, et al.
Pageof 21

Showing results (121-130 of 202) with videos related to

Sort By:
Pageof 21
Journal of the American College of Cardiology|June 17, 1998
B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS)E de Groot, J W Jukema, A D Montauban van Swijndregt, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 9, 2004
Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient miceR de Nooijer, J H von der Thüsen, C J N Verkleij, et al.
Circulation|May 15, 1995
Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)J W Jukema, A V Bruschke, A J van Boven, et al.
Journal of Lipid Research|April 7, 1999
Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteinsH E Henderson, J J Kastelein, A H Zwinderman, et al.
International Journal of Cardiology|April 7, 2018
The role of CD27-CD70-mediated T cell co-stimulation in vasculogenesis, arteriogenesis and angiogenesisK H Simons, Z Aref, H A B Peters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2005
Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesisR de Nooijer, C J N Verkleij, J H von der Thüsen, et al.
Journal of Thrombosis and Haemostasis : JTH|December 30, 2017
Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general populationI A Dekkers, R de Mutsert, A P J de Vries, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 8, 2019
Indications for an early invasive strategy in NSTE-ACS patientsB Zwart, J M Ten Berg, A W van 't Hof, et al.
Clinical Genetics|April 10, 2002
ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levelsK Y Zwarts, S M Clee, A H Zwinderman, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|June 9, 2017
Classical determinants of coronary artery disease as predictors of complexity of coronary lesions, assessed with the SYNTAX scoreJ M Montero-Cabezas, I Karalis, R Wolterbeek, et al.
Pageof 21